Egis Gyogyszergyar Nyrt

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
 
 
C07D HETEROCYCLIC COMPOUNDS 1161

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8778932 Dihydro-oxazolobenzodiazepinone compounds, a process for there preparation and pharmaceutical compositions containing themMar 07, 12Jul 15, 14[A61K, C07D]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
7951798 Polymorphs of olanzapine hydrochlorideExpiredApr 22, 04May 31, 11[A61K, C07D, A61P]
7910591 Piperazine derivatives of alkyl oxindolesExpiredMay 11, 05Mar 22, 11[A61K, C07D]
7786129 Piperazine derivatives of dialkyl oxindolesExpiredMay 11, 05Aug 31, 10[A61K, C07D]
2009/0215,855 New Crystalline Atorvastatin Hemicalcium Salt Polymorph FormAbandonedApr 07, 06Aug 27, 09[A61K, C07D]
2009/0124,606 Composition for Treatment of PsychosisAbandonedJul 12, 06May 14, 09[A61K, A61P]
2008/0194,628 Donepezil Salts Suitable for the Preparation of Pharmaceutical CompositionsAbandonedDec 09, 05Aug 14, 08[A61K, C07D, A61P]
2007/0244,102 Combination of Dermaciclane and Opoids as AnalgesicsAbandonedMar 12, 04Oct 18, 07[A61K]
2007/0232,662 Indol-2-One Derivatives for the Treatment of Central Nervous Disorders, Gastrointestinal Disorders and Cardiovascular DisordersAbandonedMay 11, 05Oct 04, 07[A61K, C07D]
2007/0219,209 Piperazine Derivatives Of Alkyl OxindolesAbandonedMay 10, 05Sep 20, 07[A61K, C07D, A61P]
2007/0142,637 Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drugAbandonedJun 30, 04Jun 21, 07[C07D]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.